Truist Financial Corp Nevro Corp Transaction History

Truist Financial Corp

$62.9 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 20, 2024	SELL	$7.96 - $13.59 $10,976 - $18,740	-1,379 Reduced 4.12%	32,079 $270,000
Q1 2024 May 10, 2024	SELL	$13.56 - $20.78 $68,315 - $104,689	-5,038 Reduced 13.09%	33,458 $483,000
Q4 2023 Feb 02, 2024	BUY	$14.18 - $22.31 $116,942 - $183,990	8,247 Added 27.26%	38,496 $828,000
Q3 2023 Nov 14, 2023	SELL	$18.22 - $25.85 $13,318 - $18,896	-731 Reduced 2.36%	30,249 $581,000
Q2 2023 Aug 01, 2023	SELL	$22.62 - $39.32 $30,265 - $52,610	-1,338 Reduced 4.14%	30,980 $787,000
Q1 2023 May 05, 2023	BUY	$30.17 - $41.11 $6,577 - $8,961	218 Added 0.68%	32,318 $1.17 Million
Q4 2022 Feb 17, 2023	BUY	$36.43 - $49.4 $327,651 - $444,303	8,994 Added 38.92%	32,100 $1.27 Million
Q3 2022 Oct 26, 2022	SELL	$40.66 - $53.03 $360,776 - $470,535	-8,873 Reduced 27.75%	23,106 $1.08 Million
Q2 2022 Jul 22, 2022	BUY	$40.85 - $77.67 $368,957 - $701,515	9,032 Added 39.36%	31,979 $1.4 Million
Q1 2022 Apr 22, 2022	SELL	$59.95 - $92.06 $321,811 - $494,178	-5,368 Reduced 18.96%	22,947 $1.66 Million
Q4 2021 Feb 14, 2022	SELL	$81.07 - $121.29 $650,748 - $973,594	-8,027 Reduced 22.09%	28,315 $2.3 Million
Q3 2021 Nov 05, 2021	SELL	$101.99 - $166.36 $82,917 - $135,250	-813 Reduced 2.19%	36,342 $4.23 Million
Q2 2021 Aug 16, 2021	BUY	$141.6 - $179.06 $722,018 - $913,026	5,099 Added 15.91%	37,155 $6.16 Million
Q1 2021 May 17, 2021	BUY	$132.81 - $182.18 $1.08 Million - $1.48 Million	8,148 Added 34.08%	32,056 $4.47 Million
Q4 2020 Nov 19, 2021	SELL	$138.17 - $184.34 $337,963 - $450,895	-2,446 Reduced 9.28%	23,908 $4.14 Million
Q4 2020 Feb 18, 2021	BUY	$138.17 - $184.34 $908,191 - $1.21 Million	6,573 Added 33.23%	26,354 $4.56 Million
Q3 2020 Nov 13, 2020	BUY	$114.09 - $145.51 $406,388 - $518,306	3,562 Added 21.96%	19,781 $2.76 Million
Q2 2020 Aug 14, 2020	BUY	$89.45 - $129.85 $222,283 - $322,677	2,485 Added 18.09%	16,219 $1.94 Million
Q1 2020 May 15, 2020	SELL	$70.23 - $144.31 $59,274 - $121,797	-844 Reduced 5.79%	13,734 $1.37 Million
Q4 2019 Feb 14, 2020	BUY	$76.41 - $117.54 $1.11 Million - $1.71 Million	14,578 New	14,578 $1.71 Million

Others Institutions Holding NVRO

# of Institutions

151

Shares Held

39.3M

Call Options Held

67.9K

Put Options Held

1.59M

Arrow Mark Colorado Holdings LLC Denver, CO

4.39M
Shares

$17.4 Million
0.35% of portfolio
Armistice Capital, LLC New York, NY

3.73M
Shares

$14.8 Million
0.35% of portfolio
Black Rock Inc. New York, NY

3.6M
Shares

$14.3 Million
0.0% of portfolio
Glenn Welling Engaged Capital LLC | Newport Beach, Ca

2.44M
Shares

$9.7 Million
2.49% of portfolio
Vanguard Group Inc Valley Forge, PA

2.1M
Shares

$8.32 Million
0.0% of portfolio

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $140M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Account